Mittwoch, 01. März 2017


  • Pressemitteilung BoxID 63534

Moody’s confirms Fresenius SE’s Ba1 rating

(lifePR) (Bad Homburg v.d.H, ) Moody's today confirmed the Ba1 corporate family rating of Fresenius SE. In July, following Fresenius' announcement of the acquisition of APP Pharmaceuticals, Inc., Moody's had placed the corporate family rating of Fresenius SE under review for possible downgrade.

The rating confirmation reflects Moody's review of the expected capital structure of the acquisition financing, the timeframe of de-leveraging and the benefits of the acquisition on the group's overall business profile. The outlook has been changed from stable to negative.

At the same time, Moody's assigned ratings for the new debt to be issued. The US$ 2.45 billion senior secured credit facility received an investment grade rating of Baa2. The US$ 1.3 billion bridge credit facility was rated at Ba1. These ratings are provisional until the acquisition is closed. The rating of the existing senior unsecured notes remains unchanged.

Stephan Sturm, Chief Financial Officer of Fresenius SE, commented: "Our financing plan for the APP acquisition aimed at minimizing any impact on our credit ratings. With all of the agencies confirming their respective pre-acquisition rating, this target has been fully accomplished."

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius AG (SE)

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care. In 2007, group sales were approx. € 11.4 billion. On June 30, 2008 the Fresenius Group had 117,453 employees worldwide. For more information visit the Company's website at www.fresenius.com .

Diese Pressemitteilungen könnten Sie auch interessieren

Resignation und Taktik - Wie Vertrauen in die EU verspielt wird

, Familie & Kind, Institut für Demographie, Allgemeinwohl und Familie e.V.

Während dieser Brief aus Brüssel verschickt wird, treffen sich die EU-Kommissare zu einer außerordentlichen Sitzung. Normalerweise findet die...

Diakonie Journalistenpreis 2017

, Familie & Kind, Diakonisches Werk der evangelischen Kirche in Württemberg e.V.

Die Diakonie in Baden-Württemberg schreibt zum 15. Mal ihren Journalistenpreis aus. Einsendeschluss ist der 30. April 2017. Die Diakonie in...

Oscarverleihung 2017: Zoomania als bester Animationsfilm ausgezeichnet

, Familie & Kind, Dorling Kindersley Verlag GmbH

“And the Oscar goes to…. Zoomania!“ Gestern Nacht war es wieder soweit – in Los Angeles wurden die 89. Academy Awards verliehen und in der Kategorie...

Disclaimer